Predicting Risk of End-Stage Liver Disease in Antiretroviral-Treated Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients

Background. End-stage liver disease (ESLD) is an important cause of morbidity among human immunodeficiency virus (HIV)/hepatitis C virus (HCV)-coinfected patients. Quantifying the risk of this outcome over time could help determine which coinfected patients should be targeted for risk factor modific...

Descripción completa

Detalles Bibliográficos
Autores principales: Lo Re, Vincent, Kallan, Michael J., Tate, Janet P., Lim, Joseph K., Goetz, Matthew Bidwell, Klein, Marina B., Rimland, David, Rodriguez-Barradas, Maria C., Butt, Adeel A., Gibert, Cynthia L., Brown, Sheldon T., Park, Lesley S., Dubrow, Robert, Reddy, K. Rajender, Kostman, Jay R., Justice, Amy C., Localio, A. Russell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536329/
https://www.ncbi.nlm.nih.gov/pubmed/26284259
http://dx.doi.org/10.1093/ofid/ofv109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536329/
https://www.ncbi.nlm.nih.gov/pubmed/26284259
http://dx.doi.org/10.1093/ofid/ofv109

Ejemplares similares